Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-3tt2zhzPhase 4Not yet recruiting
Phase 4, randomised, double-blind trial of clonidine (2 arms), sponsored by Pontifícia Universidade Católica de São Paulo. Primary endpoint: Change in Quality of Recovery-15 score. Planned start Jan 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-3tt2zhz.